[HTML][HTML] Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: still a potential druggable target?
L Braglia, M Zavatti, M Vinceti, AM Martelli… - … et Biophysica Acta (BBA …, 2020 - Elsevier
Although the prognosis of patients with localized prostate cancer is good after surgery, with
a favorable response to androgen deprivation therapy, about one third of them invariably …
a favorable response to androgen deprivation therapy, about one third of them invariably …
[PDF][PDF] Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?☆
L Braglia, M Zavatti, M Vinceti, AM Martelli, S Marmiroli - core.ac.uk
Although the prognosis of patients with localized prostate cancer is good after surgery, with
a favorable response to androgen deprivation therapy, about one third of them invariably …
a favorable response to androgen deprivation therapy, about one third of them invariably …
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
L Braglia, M Zavatti, M Vinceti, AM Martelli… - BIOCHIMICA ET …, 2020 - iris.unimore.it
Although the prognosis of patients with localized prostate cancer is good after surgery, with
a favorable response to androgen deprivation therapy, about one third of them invariably …
a favorable response to androgen deprivation therapy, about one third of them invariably …
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
L Braglia, M Zavatti, M Vinceti, AM Martelli… - … et Biophysica acta …, 2020 - europepmc.org
Although the prognosis of patients with localized prostate cancer is good after surgery, with
a favorable response to androgen deprivation therapy, about one third of them invariably …
a favorable response to androgen deprivation therapy, about one third of them invariably …
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: still a potential druggable target?
L Braglia, M Zavatti, M Vinceti, AM Martelli… - … ET BIOPHYSICA ACTA …, 2020 - cris.unibo.it
Although the prognosis of patients with localized prostate cancer is good after surgery, with
a favorable response to androgen deprivation therapy, about one third of them invariably …
a favorable response to androgen deprivation therapy, about one third of them invariably …
[引用][C] Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
L Braglia, M Zavatti, M Vinceti, AM Martelli… - … et Biophysica Acta …, 2020 - cir.nii.ac.jp
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable
target? | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
target? | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?
L Braglia, M Zavatti, M Vinceti… - … et biophysica acta …, 2020 - pubmed.ncbi.nlm.nih.gov
Although the prognosis of patients with localized prostate cancer is good after surgery, with
a favorable response to androgen deprivation therapy, about one third of them invariably …
a favorable response to androgen deprivation therapy, about one third of them invariably …
[PDF][PDF] Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target?☆
L Braglia, M Zavatti, M Vinceti, AM Martelli, S Marmiroli - iris.unimore.it
Although the prognosis of patients with localized prostate cancer is good after surgery, with
a favorable response to androgen deprivation therapy, about one third of them invariably …
a favorable response to androgen deprivation therapy, about one third of them invariably …